Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 35
  1. Apr 13, 2026 · 17:31 · MRVL · Routine +

    Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

    Marvel Biosciences Announces an Amendment to the Conversion Price for Marvel's Proposed Convertible Debenture Offering

    01
  2. Apr 13, 2026 · 17:00 · XRTX · Routine +

    XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

    XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

    02
  3. Apr 13, 2026 · 16:40 · RIZE · Material −

    Rize Oncology Announces Warrant Incentive Program

    Rize Oncology Announces Warrant Incentive Program

    03
  4. Apr 13, 2026 · 16:35 · BIOV · Routine −

    BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

    BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

    04
  5. Apr 13, 2026 · 08:30 · MBIO · Neutral

    MindBio Therapeutics Corp.

    MindBio Deploys New Technology Intox Collect(TM); Expands CNS Drug Detection Capabilities with Voice & Facial Recognition

    05
  6. Apr 13, 2026 · 08:30 · KETA · Routine −

    TripSitter Clinic Extends Lifeline via Dilutive Debt Swap as Insolvency Looms

    TripSitter Completes Debt Settlement and Announces Financing

    06
  7. Apr 13, 2026 · 08:01 · PHRM · Routine +

    PharmaTher Files Peptide Patch Patent as Stock Nears All-Time Lows Despite Pipeline Expansion

    PharmaTher Announces Filing of U.S. Patent Application for its Peptide Microneedle Patch Technology

    07
  8. Apr 13, 2026 · 07:29 · SONA · Routine +

    Histology Validates Prior Clinical Claims But Cash Burn Remains Critical

    Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies

    08
  9. Apr 13, 2026 · 07:01 · TLT · Routine +

    Theralase Preclinical Data Confirms Earlier Findings as Capital Runway Extends

    Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study

    09
  10. Apr 13, 2026 · 06:30 · CHS · Routine +

    CHS Shares Rally on SaaS Growth Confirmation Amid Dilution Concerns

    Comprehensive Healthcare Systems Issues CEO Shareholder Letter Highlighting Strategic Progress and Growth Outlook

    10
  11. Apr 12, 2026 · 19:30 · 4565 · Routine +

    Nxera Pharma Secures $22.5M Neurocrine Milestone Amidst Cash Burn Concerns

    Nxera Pharma's Partner Neurocrine Biosciences Doses First Patient in Phase 2 Trial of NBI-1117570 for Adults with Schizophrenia

    11
  12. Apr 10, 2026 · 20:00 · LOBE · Routine +

    Lobe Sciences Secures Runway with Modest Financing Amidst Strong Balance Sheet

    Lobe Sciences Ltd. Announces Non-Brokered Private Placement

    12
  13. Apr 10, 2026 · 17:42 · FNDX · Routine −

    FendX Settles Debt with Equity at Discount Amidst Cash Flow Constraints

    Fendx Technologies issues 242,102 shares for debt

    13
  14. Apr 10, 2026 · 17:05 · SHRX · Neutral

    Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs

    Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs

    14
← Newer Older →